PALATIN TECHNOLOGIES, INC. Deferred Income Tax Assets, Net
PALATIN TECHNOLOGIES, INC. (PTN) had Deferred Income Tax Assets, Net of $274.75 thousand as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2017-11-13
- 2017-09-30: Deferred Income Tax Assets, Net $274.75K.
- 2017-06-30: Deferred Income Tax Assets, Net $0.00.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2017-09-30 | $274.75K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $0.00 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |